Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Enwave Corporation | 5.960% | -10.000% | -20.313% | -42.045% | -37.805% | -83.792% | -89.861% |
Promis Neurosciences Inc. | 9.300% | 11.243% | -8.738% | -67.018% | 88.945% | -71.515% | -80.658% |
InMed Pharmaceuticals Inc. | -3.460% | 7.955% | -22.259% | -77.845% | -30.959% | -99.623% | -99.904% |
Resverlogix Corp | - | 0.000% | 0.000% | -59.444% | -15.116% | -93.814% | -98.765% |
News
EnWave Signs Technology Evaluation and License Option Agreement with Food Company Led by Michelin Star Chef
Vancouver, B.C., April 2nd, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that it has signed a Technology Evaluation and License Option Agreement
EnWave Declares Significant Sales Wins for Royalty-Partner BranchOut Food
Vancouver, B.C., February 29th, 2024, EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today announced that BranchOut Food Inc. (NASDAQ:BOF) (“BranchOut”), a royalty
EnWave Signs Royalty-Bearing Commercial License with Established South American Food Manufacturer
Vancouver, B.C., February 28th, 2024 - EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today announced that the Company has signed a new royalty-bearing commercial